MedTrace Logo

Dexmedetomidine in Children Having Transthoracic Echocardiography

NCT02523144 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 279

Last updated 2017-07-31

No results posted yet for this study

Summary

Sedation Techniques for children undergoing transthoracic echocardiography (TTE).

Conditions

Interventions

DRUG

Chloral Hydrate

70mg/kg chloral hydrate

DRUG

Dexmedetomidine

2mcg/kg

DRUG

Dexmedetomidine

3mcg/kg

DRUG

Placebo

Flavored placebo syrup

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Jeffrey Miller, MD · Children's Hospital Medical Center, Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523144 on ClinicalTrials.gov